| Financial Year |
March 31 2023 |
| Monetary Funds |
334,186,864.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
168,118,905.79 |
| Advances to Suppliers |
109,179,987.96 |
| Other Receivables |
13,314,919.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
494,055.58 |
| Dividend Receivable |
-- |
| Inventories |
104,586,242.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,509,201.26 |
| Total Current Assets |
876,824,081.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
367,275,215.04 |
| Under-construction Projects |
78,984,479.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,644,323.65 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,697,475.69 |
| Deferred Income Tax Assets |
8,477,169.69 |
| Other Non-Current Assets |
116,004,272.37 |
| Sub-Total of Non-Current Assets |
627,082,936.38 |
| Total Assets |
1,503,907,018.08 |
| Short-Term Loans |
3,686,080.73 |
| Trading Financial liabilities |
-- |
| Notes Payable |
128,465,832.32 |
| Accounts Payable |
137,116,382.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,513,164.82 |
| Taxes Payable |
6,413,439.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,500,756.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
15,813,859.66 |
| Sub-Total of Current Liabilities |
690,546,515.28 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
247,966.76 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,948,601.95 |
| Total Liabilities |
709,495,117.23 |
| Paid-In Capital(Or Share Stock) |
377,667,996.00 |
| Capital Surplus |
184,064,034.73 |
| Surplus Reserve |
26,165,177.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
185,198,819.82 |
| Minority Stockholder's Interest |
21,682,757.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
772,729,143.77 |
| Owner's Equity（Stockholder's Equity） |
794,411,900.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,503,907,018.08 |
